CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
PRINCETON, N.J., Aug. 16, 2024 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced ...
| Ticker |
Sentiment |
Impact |
|
META
|
Neutral
|
5 %
|
|
CTSO
|
Somewhat Bullish
|
40 %
|
